Companies: 10,795·Total market cap: $144.5T
Coloplast A/S

Coloplast A/S

CLPBFOTCHealthcare● Active
$57.56
$-0.08(-0.14%)
Market Cap$11.9B
P/E Ratio—
52W High$100
52W Low$57.28
Net IncomeFinancialsRevenue

Coloplast A/S (CLPBF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CLPBF · net income · updated Jun 8, 2026

Core profitability metrics

Net income was $3.63B for FY2025 (fiscal year ending 2025-09-30), down 28.2% year-over-year. Net profit margin was 13.0%. Based on available data, Coloplast A/S has been profitable since at least 2011.

FY2025 Net Income$3.63B▼ -28.2% YoY
Trailing 12M (TTM)$2.10Btrailing 4 quarters sum
Net Profit Margin13.0%$3.63B ÷ $27.82B
YoY Change-28.2%—
5-Year CAGR-2.9%FY2020 → FY2025
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · CLPBF net income history · CLPBF profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025$3.63B▼ 28.2%13.0%
FY2024$5.05B▲ +5.6%18.7%
FY2023$4.78B▲ +1.6%19.5%
FY2022$4.71B▼ 2.5%20.8%
FY2021$4.83B▲ +15.0%24.8%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Coloplast A/S
Coloplast A/SYOU
CLPBF
$3.63B-28.2%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Coloplast A/S (CLPBF) reported net income of $3.63B for FY2025 (fiscal year ending 2025-09-30), down 28.2% year-over-year. The net profit margin was 13.0% — meaning the company kept $0.13 of every dollar of revenue as profit.

Based on available data, Coloplast A/S has been profitable since at least 2011. Net income reached a peak of $5.05B in FY2024. Data available for 15 fiscal years.

Coloplast A/S's net profit margin was 13.0% for FY2025, based on the latest annual results.

Investors sometimes search for "Coloplast A/S net worth" — the company's market capitalization is a separate figure from CLPBF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.
RevenueFinancial statementsEarningsForecastPrice historyMarket capFree cash flow

Frequently asked questions

CLPBF net income · 5 questions

Coloplast A/S is profitable. The company reported net income of $3.63B for FY2025, a net profit margin of 13.0%. Net income was down 28.2% year-over-year. Based on available data, Coloplast A/S has been profitable since at least 2011.

is CLPBF profitabledoes CLPBF make a profitCLPBF profitabilityCLPBF profitable company

▸ Source: FMP /income-statement · GAAP · Coloplast A/S · Coloplast A/S SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026